BOCCHIA MONICA | Professor page

Gianesin, B., Zappu, A., Ferrero, G.B., Gaglioti, C.M., Santodirocco, M., Fania, G., et al. (2026). Real-world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron-overloaded patients. BRITISH JOURNAL OF HAEMATOLOGY, 208(6), 2320-2325 [10.1111/bjh.70437]. - view more
Tatangelo, V., Carullo, G., Lopresti, L., Ulivieri, C., Brogi, S., Butini, S., et al. (2026). Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4. APOPTOSIS, 31(7) [10.1007/s10495-026-02393-0]. - view more
Gozzetti, A., Pacelli, P., Caroni, F., Raspadori, D., Bestoso, E., Antonioli, E., et al. (2026). MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM. BRITISH JOURNAL OF HAEMATOLOGY [10.1111/bjh.70448]. - view more
Caggiano, V., Sbalchiero, J., Frassi, M., Martin-Nares, E., Hinojosa-Azaola, A., Sikora, M., et al. (2026). Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries. FRONTIERS IN MEDICINE, 12 [10.3389/fmed.2025.1659758]. - view more
Del Prete, R., Tusha, V., Simon-Molas, H., Gazziero, V.A., Nardi, F., Drago, R., et al. (2026). IL21—STAT3 controls the pentose phosphate pathway to support metabolic reprogramming and tumor progression in chronic lymphocytic leukemia. HEMASPHERE, 10(1) [10.1002/hem3.70292]. - view more

All publications